More Galleries
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More
America's favorite businesses From a science camp for girls to a kombucha brewer, communities around the country voted on their favorite small businesses. These 12 came out on top, each scoring a $250,000 grant from Chase and a trip to Google's headquarters. More

Special Offer
10 of 36
Easier TB diagnosis
Easier TB diagnosis
Dr. Christopher Rumball, Kelly Karns, Mathieu Michalet and Milena Lazarevska
Team name: AutoTB

School: University of Cambridge, Judge Business School, Cambridge, United Kingdom

Team members: Kelly Karns, Christopher Rumball, Adnan Iqbal, Milena Lazarevska, Mathieu Michalet

Concept: The founders of AutoTB have created a device that automates the analysis of sputum for tuberculosis diagnosis. They hope to put it to use in developing countries, where the disease kills two million people annually, according to the World Health Organization.

AutoTB plans to market its product primarily through refugee camps and medical centers operated by non-governmental organizations and government health authorities. The device, expected to retail for around $1,100 per unit, is designed to withstand high humidity, variable temperatures and dusty conditions, and can render a diagnosis off a single sample.

AutoTB's CEO has degrees in biomedical and mechanical engineering and experience with both medical device design and bacterial-detection software development. Other executives have backgrounds in medicine and healthcare in developing countries - as well as contacts with non-governmental organizations.

Timeline: The AutoTB timeline calls for product development, patent filing, nine months of clinical trials and a product launch within three years. - Kathleen Ryan O'Connor

NEXT: A novel treatment for a damaged heart

Last updated May 02 2008: 11:51 AM ET
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.